Dr. Reddy's Laboratories Patent-Cliff Exposure & CMS Drug Spending Portfolio
Dr. Reddy's Laboratories (Princeton, NJ): 4 reconciled FDA prescription therapies, $17.6M 2024 CMS Part D & Medicaid spend, and $2,348 CA SB 17 specialty launch WAC.
| Regulatory & Reimbursement Dimension | Verified Value |
|---|---|
| Headquarters / Cluster | Princeton, NJ |
| Reconciled FDA Portfolio Therapies | 4 |
| 2025 to 2030 Patent-Cliff Revenue Exposure | 0.0% |
| Primary Portfolio LOE Date | 2044-01-01 |
| 2024 CMS Total Public Spend | $17.6M |
| 2024 Medicare Part D Spend | $15.4M |
| 2024 Medicaid Spend | $2.3M |
| California HCAI SB 17 Filings | Specialty launch notice ($2,348 intro WAC) |